Access

Article


Nature Medicine 9, 928 - 935 (2003)
Published online: 22 June 2003 | doi:10.1038/nm893

Advantage of rare HLA supertype in HIV disease progression

Elizabeth Trachtenberg1,7, Bette Korber2,3,7, Cristina Sollars1, Thomas B Kepler3,4, Peter T Hraber3, Elizabeth Hayes1, Robert Funkhouser2,3, Michael Fugate2, James Theiler2, Yen S Hsu1, Kevin Kunstman5, Samuel Wu5, John Phair5, Henry Erlich1,6 & Steven Wolinsky5


The highly polymorphic human leukocyte antigen (HLA) class I molecules help to determine the specificity and repertoire of the immune response. The great diversity of these antigen-binding molecules confers differential advantages in responding to pathogens, but presents a major obstacle to distinguishing HLA allele–specific effects. HLA class I supertypes provide a functional classification for the many different HLA alleles that overlap in their peptide-binding specificities. We analyzed the association of these discrete HLA supertypes with HIV disease progression rates in a population of HIV-infected men. We found that HLA supertypes alone and in combination conferred a strong differential advantage in responding to HIV infection, independent of the contribution of single HLA alleles that associate with progression of the disease. The correlation of the frequency of the HLA supertypes with viral load suggests that HIV adapts to the most frequent alleles in the population, providing a selective advantage for those individuals who express rare alleles.


MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
Gradual adaptation of HIV to human host populations: good or bad news?
Nature Medicine Perspective (01 Nov 2003)
Immunopathogenesis and immunotherapy in AIDS virus infections
Nature Medicine Review (01 Jul 2003)

$rb.Type.Code